What are the updated treatment guidelines for sepsis according to the Surviving Sepsis Campaign?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Updated Surviving Sepsis Campaign Guidelines

The most critical update is that antimicrobials must be administered within 1 hour of recognizing sepsis or septic shock, with immediate resuscitation including 30 mL/kg IV crystalloid within the first 3 hours. 1, 2

Immediate Recognition and Resuscitation (First Hour)

Sepsis and septic shock are medical emergencies requiring immediate action. 2, 3

Fluid Resuscitation

  • Administer at least 30 mL/kg of IV crystalloid fluid within the first 3 hours for sepsis-induced hypoperfusion (defined as hypotension persisting after initial fluid challenge or lactate ≥4 mmol/L). 1, 2
  • Following initial fluid bolus, guide additional fluids by frequent reassessment of hemodynamic status using thorough clinical examination (heart rate, blood pressure, oxygen saturation, respiratory rate, temperature, urine output). 1, 2
  • Consider dynamic variables over static variables to predict fluid responsiveness when available. 3
  • The 2021 guidelines downgraded the initial 30 mL/kg recommendation from strong to weak, reflecting evolving evidence. 4

Antimicrobial Therapy (The Single Most Critical Intervention)

  • Administer IV antimicrobials within 60 minutes of recognizing sepsis or septic shock—this is the most important intervention for reducing mortality. 1, 2, 5
  • Use empiric broad-spectrum therapy with one or more antimicrobials covering all likely pathogens (bacterial, and potentially fungal or viral). 1, 2
  • Select drugs with adequate tissue penetration to the presumed infection source based on local resistance patterns. 2, 5

Important caveat: When the diagnosis is uncertain, the 2021 guidelines provide additional recommendations allowing clinicians time for rapid investigation in patients not in septic shock to minimize antibiotic overuse. 4, 6 However, for confirmed septic shock, immediate antibiotics remain mandatory. 2, 3

Diagnostic Studies

  • Obtain at least two sets of blood cultures (aerobic and anaerobic) before antimicrobials—one drawn percutaneously and one through each vascular access device. 1, 2
  • Never delay antimicrobials beyond 45 minutes waiting for cultures. 1, 2
  • Measure serum lactate immediately as a marker of tissue hypoperfusion and normalize it as a resuscitation endpoint. 2
  • Perform imaging studies promptly to confirm the infection source. 1, 2

Hemodynamic Support

Vasopressor Therapy

  • Target mean arterial pressure ≥65 mmHg in patients requiring vasopressors. 2, 3
  • Use norepinephrine as first-line vasopressor. 3
  • The 2021 guidelines added a new weak recommendation for peripheral initiation of vasopressors over delaying for central venous access. 4

Fluid Type

  • The 2021 guidelines include a new weak recommendation for balanced crystalloid over 0.9% saline. 4

Antimicrobial Strategy Details

Combination Therapy Indications

  • Use empiric combination therapy (at least two antibiotics of different classes) for septic shock, particularly with respiratory failure and Pseudomonas aeruginosa risk. 1, 2
  • Use combination therapy for septic shock from bacteremic Streptococcus pneumoniae (β-lactam plus macrolide). 1, 2
  • Consider combination therapy for neutropenic patients and multidrug-resistant pathogens (Acinetobacter, Pseudomonas). 1, 2
  • Do not routinely use combination therapy for ongoing treatment of most other serious infections without shock. 1

De-escalation and Duration

  • Reassess antimicrobial therapy daily for potential narrowing to single-agent therapy once susceptibility profiles are known. 1, 2
  • Limit combination therapy to 3-5 days maximum, then de-escalate to the most appropriate single therapy. 1, 2
  • Target total duration of 7-10 days for most patients. 1, 2
  • Longer courses may be needed for slow clinical response, undrainable foci, S. aureus bacteremia, fungal/viral infections, or immunodeficiency including neutropenia. 1, 2
  • Use procalcitonin levels to assist in discontinuing empiric antibiotics in patients without subsequent evidence of infection. 1, 2

Contraindications

  • Do not use antimicrobials in patients with severe inflammatory states determined to be of noninfectious cause (severe pancreatitis, burn injury). 1

Source Control

  • Implement source control interventions as soon as possible after diagnosis. 2
  • Drain or debride infected tissues when feasible. 2
  • Remove potentially infected foreign bodies or devices. 2

Corticosteroid Therapy

  • The 2021 guidelines include a new weak recommendation for IV corticosteroids in septic shock when there is ongoing vasopressor requirement. 4

Respiratory Support for Sepsis-Induced ARDS

  • Apply oxygen to achieve saturation >90%. 2
  • Use target tidal volume of 6 mL/kg predicted body weight. 3
  • Limit plateau pressures to ≤30 cm H₂O. 3
  • Use higher PEEP in patients with moderate to severe ARDS. 3
  • Consider prone positioning for PaO₂/FiO₂ ratio <150. 3
  • Maintain head of bed elevated 30-45 degrees. 2, 3

Metabolic Management

Glucose Control

  • Target blood glucose ≤180 mg/dL using a protocolized approach after initial stabilization. 2, 3
  • Monitor blood glucose every 1-2 hours until values and insulin infusion rates are stable. 3

Transfusion Threshold

  • Target hemoglobin 7-9 g/dL in the absence of tissue hypoperfusion, coronary disease, or acute hemorrhage. 2

Nutritional Support

  • Initiate early enteral feeding rather than complete fasting or IV glucose only in patients who can be fed enterally. 1, 2, 3
  • Use either early trophic/hypocaloric or early full enteral feeding; advance feeds according to patient tolerance if starting with trophic feeding. 1, 2
  • Use prokinetic agents for feeding intolerance. 1, 2
  • Place post-pyloric feeding tubes in patients with feeding intolerance or high aspiration risk. 1, 2
  • Avoid omega-3 fatty acids, IV selenium, arginine, and glutamine supplementation. 1, 2

Systems and Performance Improvement

  • Implement hospital-wide sepsis screening programs for acutely ill, high-risk patients. 1, 2, 3
  • Establish multidisciplinary teams including physicians, nurses, pharmacy, and respiratory therapy. 2
  • Use sepsis bundles and protocols with regular education and performance feedback. 2

Goals of Care and Long-Term Outcomes

  • Discuss goals of care and prognosis with patients and families, ideally within 72 hours of ICU admission. 1, 2, 3
  • Incorporate palliative care principles into treatment planning when appropriate. 1, 2, 3
  • The 2021 guidelines added 12 new recommendations addressing long-term outcomes, including strong recommendations to screen for economic and social support, use shared decision-making in discharge planning, reconcile medications at ICU and hospital discharge, provide written and verbal information about sepsis sequelae, and assess for physical, cognitive, and emotional problems after discharge. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sepsis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

What is new and different in the 2021 Surviving Sepsis Campaign guidelines.

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2023

Research

Empiric Antibiotics for Sepsis.

Surgical infections, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.